{
    "organizations": [],
    "uuid": "8542d6a30ccc09138b4bfe87bab9946da7816ed7",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-sam-chun-dang-pharm-signs-contract/brief-sam-chun-dang-pharm-signs-contract-worth-3-17-bln-won-idUSL4N1QG1PD",
    "ord_in_thread": 0,
    "title": "BRIEF-Sam Chun Dang Pharm signs contract worth 3.17 bln won",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 26 (Reuters) - Sam Chun Dang Pharm Co Ltd :\n* Says it signed a 3.17 billion won contract with Omnivision GMBH to provide collyrium incrementally modified drug in Europe\nSource text in Korean: goo.gl/tuWiZm\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-02-26T11:06:00.000+02:00",
    "crawled": "2018-02-26T16:57:38.002+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "sam",
        "chun",
        "dang",
        "pharm",
        "co",
        "ltd",
        "say",
        "signed",
        "billion",
        "contract",
        "omnivision",
        "gmbh",
        "provide",
        "collyrium",
        "incrementally",
        "modified",
        "drug",
        "europe",
        "source",
        "text",
        "korean",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}